Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lief Bjermer"'
Autor:
Kathryn Mesh, Kun Peng, John G. Matthews, Prescott G. Woodruff, Wendy S. Putnam, Melissa Gonzalez Edick, Elliot Israel, Peter Bradding, Margaret Solon, Francis Abreu, Arnaud Bourdin, Kit Wong, Monet Howard, Monica Kraft, Cecile T.J. Holweg, Joseph R. Arron, Cary D. Austin, J. Mark FitzGerald, Gail M. Gauvreau, David F. Choy, Fang Cai, Ronald E. Ferrando, Lief Bjermer, Miriam Baca, Julie Olsson, Clavier Investigators, Kaharu Sumino
Publikováno v:
Clinical and Experimental Allergy
Clinical and Experimental Allergy, Wiley, In press, ⟨10.1111/cea.13731⟩
Clinical and Experimental Allergy, In press, ⟨10.1111/cea.13731⟩
Clinical and Experimental Allergy, Wiley, In press, ⟨10.1111/cea.13731⟩
Clinical and Experimental Allergy, In press, ⟨10.1111/cea.13731⟩
Background The anti-interleukin 13 (IL-13) monoclonal antibody lebrikizumab improves lung function in patients with moderate-to-severe uncontrolled asthma, but its effects on airway inflammation and remodelling are unknown. CLAVIER was designed to as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e09f921ff0a596f26f42c8645f7cfe
http://europepmc.org/articles/PMC7756263
http://europepmc.org/articles/PMC7756263
Autor:
Jonas Román, Göran Eckerwall, Ola Beckman, L.-P. Boulet, D. S. Postma, Tore Persson, Paul M. O'Byrne, M. van den Berge, Gail M. Gauvreau, Lief Bjermer, Marie Carlholm, K-M Schutzer
Publikováno v:
Thorax. 71:A155.2-A155
Background/objective To demonstrate therapeutic equivalence of terbutaline via two different Turbuhaler® devices by evaluating its protective effect against methacholine-induced bronchoconstriction in patients with stable asthma. Methods In this dou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e995b1d48a9124359d7769fc84eb8be5
https://doi.org/10.1136/thoraxjnl-2016-209333.277
https://doi.org/10.1136/thoraxjnl-2016-209333.277
Autor:
Maria Pia Villa, Alberto Villani, Roberto Ronchetti, Thomas Sandström, Fabio Midulla, J. Zebrak, Jacek Pawlik, Lief Bjermer
The aim of the present study was to compare cellular and noncellular components of bronchoalveolar lavage fluid (BAL) in a group of children with a diagnosis of chronic diffuse parenchymal lung disease (cDPLD) and a group of children without parenchy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f4612c614baf8bfcb6f8dd1ec3d9459
http://hdl.handle.net/11573/244463
http://hdl.handle.net/11573/244463
Autor:
Alberto Villani, Lief Bjermer, Fabio Midulla, Thomas Sandström, Roberto Ronchetti, Rocco Merolla
Publikováno v:
Pediatric pulmonology. 20(2)
We evaluated bronchoalveolar lavage fluid (BAL) for cellular constituents, concentration of total protein (TP), albumin (AL), fibronectin (FN), and hyaluronic acid (HA) in 16 children aged 2-32 months without pulmonary inflammatory or parenchymal dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c48352df59f5e73a0811d64fe18790
https://pubmed.ncbi.nlm.nih.gov/8570301
https://pubmed.ncbi.nlm.nih.gov/8570301